One platform. Three purpose-built products.
From biomarker discovery to clinical trials, life sciences leaders rely on Concentriq LS to fast-track breakthroughs and turn siloed pathology data into a competitive advantage.
Leading academic medical centers, health systems, and commercial labs leverage Concentriq AP’s advanced digitization and AI to go fully digital — and never look back.
FDA-cleared for primary diagnosis, Concentriq AP-Dx offers an intuitive experience for interpreting and managing cases, advancing both late-stage clinical trials and diagnostic workflows.
Concentriq is the most trusted enterprise digital pathology platform. Find out why.
Explore our solutions from discovery to diagnosis
Discover, develop, deliver — faster
Deploy Concentriq, Proscia Aperture, and AI across the R&D lifecycle to bring treatments to market faster and reach more patients worldwide.
Run a modern, more productive lab
Accelerate your shift to 100% digital diagnosis — improve diagnostic quality, increase efficiency, and position your lab for future growth.
Accelerate precision medicine with AI
From development tools to analysis applications, scientists and pathologists can build and deploy AI solutions that accelerate therapy development and deliver precision diagnostics.
Access real-time, point-of-diagnosis patient insights
Proscia Aperture is a precision medicine solution that turns data into insight at the moment of diagnosis. Accelerate drug development and generate real-world evidence for market access strategies.
Visionaries trust our vision
Leaders like PathGroup partner with us to help them rewire pathology for precision medicine. They know that our approach to digital pathology and AI is the key to smart, scalable growth and better patient care.
“With Proscia, we are going 100% digital to accelerate growth, improve our pathologist experience, and open new data opportunities with leading pharmas and CROs.”
Dr. Derek Welch, MD, FCAP, Chief Medical Officer, PathGroup
More than 12,000 pathologists and scientists use our platform daily at diagnostic laboratories and life sciences organizations, including major CROs and 16 of the top 20 pharma leaders.
Proscia Leads The Way Forward in Digital Pathology
We’re proud to be recognized for these outstanding achievements as we advance our mission to change the way we fight diseases like cancer.
Latest News & Events
Event
USCAP 2026: Pathology is Human Work. Expertise Matters.
March 23-25, 2026
Find out what this means for you, and your lab, at USCAP 2026. Proscia will be in San Antonio with a full slate of events, demos, and conversations about the future of digital pathology. Visit our event page to easily schedule a meeting with one of our experts, and get a firsthand experience of Concentriq. We hope to see you there.
Webinar
Beyond the Image: Powering the Future of Life Sciences Research with Concentriq LS
On Demand | 11:30am ET
Join us as we demo the latest Concentriq LS releases, which are designed to help biopharma, biotech, and CRO teams analyze faster, collaborate smarter, and stay ready for the future of image-based discovery. If your team is slowed down by manual annotations, inefficient image navigation, or disconnected AI tools, this live session will demonstrate how Concentriq LS’s latest updates remove these bottlenecks and streamline your research workflows.
Press Release
Proscia Raises $50M To Advance AI-Driven Pathology And Deliver The Future Of Precision Medicine
Study Report
Rewiring Pathology for Precision Drug Discovery and Development: A scientific review of the evidence behind digital pathology and AI’s transformative role in biopharma R&D
Buyer's Guide
Free Resource for Pathology Leaders: The Strategic Buyer's Guide to Evaluating Digital Pathology Platforms